A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne virus capable of causing a severe hemorrhagic fever disease in humans. There are currently no licensed vaccines to prevent CCHFV-associated disease. We developed a DNA vaccine expressing the M-segment glycoprotein precursor gene of CCHFV...
Saved in:
Main Authors: | Aura R Garrison (Author), Charles J Shoemaker (Author), Joseph W Golden (Author), Collin J Fitzpatrick (Author), John J Suschak (Author), Michelle J Richards (Author), Catherine V Badger (Author), Carolyn M Six (Author), Jacqueline D Martin (Author), Drew Hannaman (Author), Marko Zivcec (Author), Eric Bergeron (Author), Jeffrey W Koehler (Author), Connie S Schmaljohn (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
by: Marko Zivcec, et al.
Published: (2018) -
Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles.
by: Marko Zivcec, et al.
Published: (2015) -
Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates
by: John J. Suschak, et al.
Published: (2019) -
Seroepidemiological Studies of Crimean-Congo Hemorrhagic Fever Virus in Domestic and Wild Animals.
by: Jessica R Spengler, et al.
Published: (2016) -
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
by: John J. Suschak, et al.
Published: (2017)